FRANKLIN COVEY CO. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
FRANKLIN COVEY CO. (FC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$1.47 million for the 12-month period ending 2025-08-31, per its 10-K filed 2025-11-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-11-12
- FRANKLIN COVEY CO. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$1.47M.
- FRANKLIN COVEY CO. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$1.15M, a 410.22% decline from fiscal 2023.
- FRANKLIN COVEY CO. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $372.00K, a 86.92% decline from fiscal 2022.
- FRANKLIN COVEY CO. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $2.85M, a 73.02% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-08-31 | -$1.47M 10-K · filed 2025-11-12 |
| 2024-08-31 | -$1.15M 10-K · filed 2025-11-12 |
| 2023-08-31 | $372.00K 10-K · filed 2025-11-12 |
| 2022-08-31 | $2.85M 10-K · filed 2024-11-12 |
| 2021-08-31 | $10.55M 10-K · filed 2023-11-13 |
| 2020-08-31 | -$11.26M 10-K · filed 2022-11-14 |
| 2019-08-31 | -$418.00K 10-K · filed 2021-11-12 |
| 2018-08-31 | -$2.78M 10-K · filed 2020-11-16 |
| 2017-08-31 | -$129.00K 10-K · filed 2019-11-14 |
| 2016-08-31 | -$301.00K 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |